Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BioNeutra Global's share price for the quarter that ended in Dec. 2023 was C$0.02. BioNeutra Global's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 46.45 Mil. Therefore, BioNeutra Global's market cap for the quarter that ended in Dec. 2023 was C$0.93 Mil.
BioNeutra Global's quarterly market cap
declined
from Jun. 2023 (C$3.04 Mil) to Sep. 2023 (C$1.40 Mil) and
declined
from Sep. 2023 (C$1.40 Mil) to Dec. 2023 (C$0.93 Mil).
BioNeutra Global's annual market cap
declined
from Dec. 2021 (C$7.90 Mil) to Dec. 2022 (C$0.93 Mil) but then
stayed the same
from Dec. 2022 (C$0.93 Mil) to Dec. 2023 (C$0.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BioNeutra Global's Enterprise Value for Today is C$9.93 Mil.
BioNeutra Global Market Cap Historical Data
The historical data trend for BioNeutra Global's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioNeutra Global's Market Cap
For the Packaged Foods subindustry, BioNeutra Global's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioNeutra Global's Market Cap Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioNeutra Global's Market Cap distribution charts can be found below:
* The bar in red indicates where BioNeutra Global's Market Cap falls into.
BioNeutra Global Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BioNeutra Global's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioNeutra Global (TSXV:BGA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BioNeutra Global Market Cap Related Terms
Thank you for viewing the detailed overview of BioNeutra Global's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
BioNeutra Global Corp is engaged in the research, development, production, and commercialization of food ingredients for neutraceutical, functional and mainstream foods, focusing on oligosaccharides. Its product portfolio provides ingredients for various food systems, that contribute to human nutrition and wellness in functional and healthy foods. Its prime product, VitaFiber IMO, is offered in both powder and syrup form. The company operates in Canada while generating sales revenue from various countries internationally. It has a single industry segment, manufacturing and trading of products. The majority of the revenue is derived from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:BGA has been successfully added to your 